Reminder: Join Us Tomorrow for a Virtual Public Meeting on Patient-Generated Health Data Throughout the Total Product Life Cycle of Medical Devices The U.S. Food and Drug Administration (FDA) will host a virtual public meeting entitled Patient-Generated Health Data Throughout the Total Product Life Cycle of Medical Devices. The purpose of this public meeting is to discuss patient-generated health data (PGHD) and its potential impact across the health care system. PGHD includes health-related data that is created, recorded, or gathered by or from patients, such as health and treatment history, biometric data, symptoms, and lifestyle habits. This meeting is the intersection of CDRH efforts in patient science and engagement, real-world data and real-world evidence, and the Digital Health Center of Excellence. Topics include: Sources of PGHD, data quality measures, interoperability, and potential impacts of the data in regulatory and health care settings. - Meeting Date: Tuesday, May 4, 2021, 10:00 a.m. - 4:00 p.m. EDT
- Location: This public meeting will be webcast.
- Registration Deadline: Monday, May 3, 2021 by 4:00 p.m. EDT
Questions? If you have questions about this virtual public meeting, contact Christina Webber Christina.Webber@fda.hhs.gov. |
No comments:
Post a Comment